Targeted Therapies Linked to Survival Benefits for Older Patients With Advanced Renal Cancer Targeted Therapies Linked to Survival Benefits for Older Patients With Advanced Renal Cancer

Targeted therapies were associated with"modest survival advantages" in elderly Medicare patients with metastatic renal cell carcinoma (mRCC) in a retrospective study.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news